We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Are German Health Insurers Obliged to Purchase Drugs by Public Tender?

01 August 2007

Just three months ago, reforms to the German healthcare system came into effect bringing profound changes to the market for pharmaceuticals. Cost-benefit analyses and compulsory second opinions have been introduced into the prescribing process, and payers and care providers now have more power to negotiate. Bettina Tugendreich and Maren Bedau examine companies' legal rights in the face of the reforms.
Loading data